Rodolfo Pizarro

ORCID: 0009-0003-8063-8820
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiac Imaging and Diagnostics
  • Organ Transplantation Techniques and Outcomes
  • Neuroscience of respiration and sleep
  • Restraint-Related Deaths
  • Medical Imaging and Pathology Studies
  • Thyroid Disorders and Treatments
  • Mechanical Circulatory Support Devices
  • Acute Lymphoblastic Leukemia research
  • Parathyroid Disorders and Treatments
  • Cardiac Valve Diseases and Treatments
  • Acute Myeloid Leukemia Research
  • Cardiac Health and Mental Health
  • Atrial Fibrillation Management and Outcomes
  • Cardiac tumors and thrombi
  • DNA Repair Mechanisms
  • Metabolism and Genetic Disorders
  • Mitochondrial Function and Pathology
  • Peptidase Inhibition and Analysis
  • Health Systems, Economic Evaluations, Quality of Life
  • Birth, Development, and Health
  • Transplantation: Methods and Outcomes

Hospital Italiano de Buenos Aires
2002-2025

Washington University in St. Louis
2013

Objectives. Patients diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience poor outcomes due to the development of heart failure (HF). Tricuspid regurgitation (TR) has been found be correlated adverse in patients HF. This study aims assess whether presence significant TR is associated cardiac ATTR-CM. Materials and methods. Retrospective ATTR-CM enrolled Institutional Registry Amyloidosis (NCT01347047). were categorized based on (moderate or severe according current...

10.47487/apcyccv.v5i2.388 article EN cc-by Archivos Peruanos de Cardiología y Cirugía Cardiovascular 2024-06-20

Abstract Introduction Transthyretin Amyloid cardiomyopathy (ATTR-CM) usually presents as heart failure with preserved ejection fraction (HFpEF). Its diagnosis has a significant clinical impact, specific treatment is currently available. Purpose To assess the prevalence of ATTR-CM in patients hospitalised for HFpEF and increased septal thickness our institution general community hospital Latin America (LATAM). Methods Cross-sectional study. Patients (>50%) ≥ 12 mm during period from...

10.1093/eurheartj/ehae666.789 article EN European Heart Journal 2024-10-01

Abstract Introduction Heart Failure with preserved ejection fraction (HFpEF) is a significant clinical concern, characterized by rising prevalence and substantial morbidity. Despite the frequent presence of secondary tricuspid regurgitation (TR) in this population, its prognostic implications remain unknown. Purpose The aim study to assess rate composite mortality heart failure readmissions considering hemodynamically TR patients hospitalised for HFpEF. Methods Prospective observational...

10.1093/eurheartj/ehae666.788 article EN European Heart Journal 2024-10-01

10.1053/euje.2001.0079 article European Journal of Echocardiography 2002-06-01
Coming Soon ...